Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) EBITDA

Alert me on EBITDA

Chemed Corporation's EBITDA for fiscal 2025 was $403.4M, down 6.15% from $429.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $438.8M. Over the past ten years it has ranged from $150.4M (fiscal 2017) to $446.6M (fiscal 2020); the current reading is higher than 82% of that period. Chemed Corporation ranks 14th of 48 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $403.4M (6.15%)
FY2024 $429.9M 6.93%
FY2023 $402.0M (0.25%)
FY2022 $403.0M 0.15%
FY2021 $402.4M (9.89%)
FY2020 $446.6M 47.44%
FY2019 $302.9M 6.88%
FY2018 $283.4M 88.41%
FY2017 $150.4M (30.29%)
FY2016 $215.8M (2.19%)

Quarterly newest first

Period EBITDA Change
Sep 2026 $113.9M 7.19%
Jun 2026 $106.3M 4.67%
Mar 2026 $101.5M (13.27%)
Dec 2025 $117.1M 28.55%
43 more quarters

Against its own ten years

Low $150.4M High $446.6M
Ten-year median $402.0M
Current reading's percentile 82

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on CHE